4
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/ Rex-coding sequence

, , , , , & show all
Pages 330-335 | Received 09 Jan 1996, Accepted 28 Jun 1996, Published online: 10 Jul 2009

References

  • Elovaara I, Koenig S, Brewah A Y, Woods R M, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-l)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 1993; 117: 1567–1573
  • Felber B K, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis G N. The pX protein of HTLV-1 is a transcriptional activator of its long terminal repeats. Science 1985; 229: 675–679
  • Fujisawa J, Seiki M, Kiyokawa K, Yoshida M. Functional activation of the long terminal repeat of human T-cell leukemia virus type 1 by a trans-acting factor. Proc Natl Acad Sci USA 1985; 82: 2277–2281
  • Fujisawa J, Seiki M, Sato M, Yoshida M. A transcriptional enhancer of HTLV-1 is responsible for trans-activation mediated by p40x of HTLV-1. EMBO J 1986; 5: 713–718
  • Gessain A, Barin F, Vernant J C, Gout O, Maurs L, Calende A, de The G. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985; ii: 1247–1248
  • Gessain A, Gallo R C, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type 1 genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992; 66: 2288–2295
  • Hinuma Y, Nagata K, Misaka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S, Miyoshi I. Adult T cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476–6480
  • Inoue J, Yoshida M, Seiki M. Transcriptional (p40x) and posttranscriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type 1 genes. Proc Natl Acad Sci USA 1987; 84: 3653–3657
  • Jacobson S, Shida H, McFarlin D E, Fauci A S, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease. Nature 1990; 348: 245–248
  • Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H, Harada S. Target epitope in the Tax protein of human T-cell leukemia virus type-1 recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol 1992; 66: 2928–2933
  • Kira J, Koyanagi Y, Yamada T, Itoyama Y, Tateishi J, Akizuki S, Kishikawa M, Baba E, Nakamura M, Suzuki J, Nakamura T, Nakamura N, Yamamoto N, Goto I. Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 1994; 36: 149–156
  • Kiyokawa T, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M. Association of die pX gene product of human T-cell leukemia virus type-1 with nucleus. Virology 1985; 147: 462–465
  • Maniatis T, Fritsch E F, Sambrook J. Molecular cloning. A laboratory manual Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1982
  • Mochizuki M, Watanabe T, Yamaguchi K, Yoshimura K, Nakashima S, Shirao M, Araki S, Takatsuki K, Mori S, Miyata N. Uveitis associated with human T-cell lymphotropic virus type I. Am J Opthalmol 1992; 114: 123–128
  • Nagashima K, Yoshida M, Seiki M. A single species of pX mRNA of human T-cell leukemia virus type 1 encodes trans-activator p40x and two other phosphoproteins. J Virol 1986; 60: 394–399
  • Niewiesk S, Daenke S, Parker C E, Taylor G, Weber J, Nightingale S, Bangham C RM. The trans-activator gene of human T-cell leukemia virus type-1 is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 1994; 68: 6778–6781
  • Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; i: 1031–1032
  • Parker E P, Nightingale S, Taylor G P, Weber J, Bangham C RM. Circulating anti-Tax cytotoxic Tlymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 1994; 68: 2860–2868
  • Paskalis H, Felber B K, Pavlakis G N. Cis-acting sequences responsible for the transcriptional activation of a human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci USA 1986; 83: 6558–6562
  • Poiesz B J, Ruscetti R W, Gazdar A F, Bunn P A, Minna J D, Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–7419
  • Saito M, Furukawa Y, Kubota R, Usuku K, Sonoda S, Izumo S, Osame M, Yoshida M. Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. J Neurovirol 1995; 1: 286–294
  • Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983; 80: 3618–3622
  • Seiki M, Inoue J I, Takeda T, Yoshida M. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-activating transcriptional activator. EMBO J 1986; 5: 561–565
  • Shimotohno K, Takano M, Teruuchi T, Miwa M. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc. Natl Acad Sci USA 1986; 83: 8112–8116
  • Shirabe S, Nakamura T, Tsujihata M, Nagataki S, Seiki M, Yoshida M. Retrovirus from human T-cell leukemia virus type 1-associated myelopathy is the same strain as a prototype human T-cell leukemia virus type 1. Arch Neurol 1990; 47: 1258–1260
  • Sodroski J G, Rosen C A, Haseltine W A. Transacting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984; 225: 381–385
  • Toyoshima H, Itoh M, Inoue J, Seiki M, Takaku F, Yoshida M. Secondary structure of the human T-cell leukemia virus type 1 rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs. J Virol 1990; 64: 2825–2832
  • Tsujimoto A, Teruuchi T, Imamura J, Shimotohno K, Miyoshi I, Miwa M. Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). Mol Biol Med 1988; 5: 29–42
  • Umehara F, Izumo S, Nakagawa M, Ronquillo A T, Takahashi K, Matsumuro K, Sato E, Osame M. Immunocytochemical analysis of die infiltrate in the spinal cord lesions in HTLV-1-associated myelopadiy. J Neuropathol Exp Neurol 1993; 52: 424–430
  • Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031–2035
  • Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in disease. Proc. Natl Acad Sci USA 1984; 81: 2534–2537
  • Yoshida M, Seiki M. Recent advances in molecular biology of HTLV-1. Annu Rev Immunol 1987; 5: 541–559

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.